Apr 30, 2019 - INCY earnings call for the period ending March 31, 2019.
Apr 30, 2019 - Incyte Corporation (NASDAQ:INCY) Q1 2019 Earnings Conference Call April 30, 2019 08:00 AM ET Company Participants Mike Booth - IR Hervé Hoppenot - CEO Barry Flannelly - EVP, General Manager, U.S. Stev
Apr 30, 2019 - While Incyte's (INCY) earnings and revenues beat estimates in Q1, Jakafi sales fall short of the same.
Apr 29, 2019 - Incyte (INCY) is slated to report first-quarter results on Apr 30. Investors will primarily focus on Jakafi sales and pipeline updates.
Apr 29, 2019 - Sarepta Therapeutics' (SRPT) Exondys 51 likely to drive first-quarter sales.
Apr 26, 2019 - Strong sales of Glaxo's (GSK) Vaccines segment is likely to drive the top line in the first quarter.
Apr 24, 2019 - On Vertex's (VRTX) first-quarter earnings call, investor focus will be on its latest CF drug Symdeko's sales figure as well as the update on its CF triple-pill regimes.
Apr 24, 2019 - Amarin's (AMRN) cardiovascular drug, Vascepa to drive sales in the first quarter.
Apr 24, 2019 - During Trevena's (TRVN) first-quarter 2019 conference call, investor focus will be on the company's progress to support its development of the pain therapy ??? oliceridine injection.
Apr 23, 2019 - AstraZeneca (AZN) will report first-quarter results on Apr 26. New drugs likely to drive sales.